HLA-DOB |
HLA-DOB: HLA class II histocompatibility antigen, DO beta chain precursor |
NULL |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-67 alpha chain precursor |
2.622 |
Evidence |
|
CHN2 |
CHN2, ARHGAP3, BCH: Beta-chimaerin |
PTK7 |
PTK7, CCK4: Tyrosine-protein kinase-like 7 precursor |
2.622 |
Evidence |
|
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
NTRK3 |
IPI00289961 |
2.622 |
Evidence |
|
SH2D1A |
SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A |
NTRK1 |
NTRK1, TRK: High affinity nerve growth factor receptor precursor |
2.622 |
Evidence |
|
KCNA5 |
KCNA5: Potassium voltage-gated channel subfamily A member 5 |
KCND3 |
KCND3: Potassium voltage-gated channel subfamily D member 3 |
2.622 |
Evidence |
|
NULL |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-38 alpha chain precursor |
HLA-E |
HLA-E, XXbac-BPG34K20.2-001: MHC class Ib antigen |
2.622 |
Evidence |
|
CACNA1G |
IPI00219398 |
TRPC1 |
TRPC1, TRP1: Short transient receptor potential channel 1 |
2.622 |
Evidence |
|
IFI16 |
IFI16, IFNGIP1: Gamma-interferon-inducible protein Ifi-16 |
CARD15 |
NOD2, CARD15, IBD1: Nucleotide-binding oligomerization domain-containing protein |
2.622 |
Evidence |
|
KCNE1 |
KCNE1: Potassium voltage-gated channel subfamily E member 1 |
KCNQ1 |
KCNQ1, KCNA8, KCNA9, KVLQT1: Potassium voltage-gated channel subfamily KQT membe |
2.622 |
Evidence |
|
SIM1 |
SIM1: Single-minded homolog 1 |
MXD1 |
MXD1, MAD: MAD protein |
2.622 |
Evidence |
|
SCN11A |
SCN11A, PN5, SCN12A, SNS2: Sodium channel protein type 11 subunit alpha |
PKD2 |
IPI00718868 |
2.622 |
Evidence |
|
FES |
FES, FPS: Proto-oncogene tyrosine-protein kinase Fes/Fps |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
2.622 |
Evidence |
|
MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
SHC2 |
IPI00401979 |
2.622 |
Evidence |
|
ASCL2 |
ASCL2: Achaete-scute homolog 2 |
TCFL5 |
TCFL5, CHA, E2BP1: Transcription factor-like 5 protein |
2.622 |
Evidence |
|
KCNQ3 |
KCNQ3: Potassium voltage-gated channel subfamily KQT member 3 |
TRPC1 |
TRPC1, TRP1: Short transient receptor potential channel 1 |
2.622 |
Evidence |
|
DEDD2 |
DEDD2, FLAME3, PSEC0004: DNA-binding death effector domain-containing protein 2 |
CARD9 |
IPI00072229 |
2.622 |
Evidence |
|
HRK |
HRK, BID3: Activator of apoptosis harakiri |
BCL2L12 |
BCL2L12, BPR: Bcl-2-related proline-rich protein |
2.622 |
Evidence |
|
TCF3 |
IPI00216911 |
BHLHB8 |
BHLHB8, MIST1: Class B basic helix-loop-helix protein 8 |
2.622 |
Evidence |
|
CACNA1C |
CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1: Voltage-dependent L-type calcium chann |
HCN4 |
HCN4: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated chann |
2.622 |
Evidence |
|
HLA-DOB |
HLA-DOB: HLA class II histocompatibility antigen, DO beta chain precursor |
HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-81 alpha chain precursor |
2.622 |
Evidence |
|
BID |
BID: BH3-interacting domain death agonist |
BBC3 |
BBC3, PUMA: Bcl-2-binding component 3 |
2.622 |
Evidence |
|
TRPC6 |
TRPC6, TRP6: Short transient receptor potential channel 6 |
MFN1 |
MFN1: Mitofusin-1 |
2.622 |
Evidence |
|
TRPA1 |
TRPA1, ANKTM1: Transient receptor potential cation channel subfamily A member 1 |
CACNA1F |
CACNA1F: Uncharacterized protein CACNA1F |
2.622 |
Evidence |
|
CD1C |
CD1C: T-cell surface glycoprotein CD1c precursor |
HLA-C |
HLA-C, D6S204, HLA-JY3, HLAC: HLA class I histocompatibility antigen, Cw-17 alph |
2.622 |
Evidence |
|
BMF |
BMF: Bcl-2-modifying factor |
BBC3 |
BBC3, PUMA: Bcl-2-binding component 3 |
2.622 |
Evidence |
|